Quarterly report pursuant to sections 13 or 15(d)

Warrants

v2.4.0.8
Warrants
3 Months Ended
Mar. 31, 2014
Text Block [Abstract]  
Warrants

Note 8. Warrants

We have issued certain warrants which contain an exercise price adjustment feature in the event we issue additional equity instruments at a price lower than the exercise price of the warrant. The warrants are described herein as derivative warrants. For all derivative warrants, in the event equity instruments are issued at a price lower than the exercise price of the warrant, the exercise price is adjusted to the price of the new equity instruments issued (price adjustment feature). For certain of these warrants, the number of shares underlying the warrant was also adjusted to an amount computed by dividing the proceeds of the warrant under its original terms by the revised exercise price (share adjustment feature). These warrants are initially recorded as a warrant liability at fair value with a corresponding entry to the loan guarantee fee asset, debt discount, additional paid-in capital or expense dependent upon the service provided in exchange for the warrant grant. Subsequently, any change in fair value is recognized in earnings until such time as the warrants are exercised, amended or expire. As of March 31, 2014 all warrants with a share adjustment feature have either expired or have been exercised.

In January 2014, the Company received $950 from a warrant holder who exercised warrants to purchase 95 shares of common stock at $10.00 per share. In February 2014 a warrant holder exercised warrants to purchase 3,320 shares of common stock at an exercise price of $10.00 per share using the net issuance exercise method whereby 1,661 shares were surrendered in payment in full of the exercise price resulting in a net issuance of 1,659 shares. In March 2014 a warrant holder exercised warrants to purchase 12,500 shares of common stock at an exercise price of $10.00 per share using the net issuance exercise method whereby 7,230 shares were surrendered in payment in full of the exercise price resulting in a net issuance of 5,270 shares.

 

The following table summarizes the warrant activity for the three months ended March 31, 2014:

 

Issued With / For

   Exercise
Price
    Warrants
Outstanding
January 1,
2014
     2014
Warrants
Exercised
    Warrants
Outstanding
March 31,
2014
 

Non-Derivative Warrants:

         

Financing

   $ 10.00        243,334         —          243,334   

Financing

     15.00        436,079         —          436,079   

Debt Guarantee

     4.00        174,288         —          174,288   

Debt Guarantee

     10.00        237,500         —          237,500   

Debt Guarantee

     15.00        585,645         —          585,645   

Consulting

     10.00        29,138         —          29,138   
  

 

 

   

 

 

    

 

 

   

 

 

 
     12.38 C      1,705,984         —          1,705,984   

Derivative Warrants:

         

Financing

     10.00 B      60,000         —          60,000   

Debt Guarantee

     10.00 A      12,500         (12,500     —     

Series B Pref. Stock

     10.00 B      18,430         (3,415     15,015   

Consulting

     10.00 B      200         —          200   
  

 

 

   

 

 

    

 

 

   

 

 

 
     10.00 C      91,130         (15,915     75,215   
  

 

 

   

 

 

    

 

 

   

 

 

 
   $ 12.28 C      1,797,114         (15,915     1,781,199   
  

 

 

   

 

 

    

 

 

   

 

 

 

 

A  These warrants are subject to fair value accounting and contain exercise price and number of share adjustment features. See Note 9.
B  These warrants are subject to fair value accounting and contain an exercise price adjustment feature. See Note 9.
C  Weighted average exercise prices are as of March 31, 2014.